Brevetti CEA is proud to have contributed to a project that has received international recognition at the 2026 ISPE Facility of the Year Awards (FOYA), one of the most prestigious awards programs in the pharmaceutical industry.
Our customer, Hepalink, was honored in the Innovation – Novel Technology category for its new pre-filled syringe manufacturing facility in Pingshan, China. The award recognizes excellence in pharmaceutical manufacturing and celebrates the implementation of advanced technologies that drive innovation, efficiency, and product quality.
As part of this ambitious project, Brevetti CEA supplied its inspection technology, integrated into the production process to support the highest standards of quality assurance and product integrity. We worked alongside Hepalink and other technology partners to help bring this state-of-the-art facility to life.
On October 18, our Sales Director, Massimo Contri, attended the FOYA awards ceremony in Washington, D.C., together with representatives from Hepalink and the other companies involved in the project.
Seeing our solutions play a role in a facility recognized on an international stage is a source of great pride for our team. This achievement reflects the value of collaboration, innovation, and technological excellence across the pharmaceutical manufacturing supply chain.
We extend our sincere congratulations to Hepalink on this well-deserved recognition and are honored to have contributed to such a significant milestone.
Awards and recognitions such as the ISPE FOYA confirm the importance of investing in advanced manufacturing technologies and quality-driven processes to support the future of pharmaceutical production worldwide.
